Qi Chao Selected Research

N-Acylsphingosine Galactosyltransferase

1/2021

Substrate reduction therapy for Krabbe disease and metachromatic leukodystrophy using a novel ceramide galactosyltransferase inhibitor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Qi Chao Research Topics

Disease

5	Neoplasms (Cancer) 11/2015 - 05/2007
2	Multiple Myeloma 01/2017 - 11/2015
1	Globoid Cell Leukodystrophy (Krabbe Disease) 01/2021
1	Metachromatic Leukodystrophy (Sulfatide Lipidosis) 01/2021
1	Lymphocytosis 01/2021
1	Leukemia 01/2017
1	Sarcoma (Soft Tissue Sarcoma) 02/2012
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2009

Drug/Important Bio-Agent (IBA)

1	psychosine-3'-sulfate esterIBA 01/2021
1	Galactosylceramides (Galactocerebrosides)IBA 01/2021
1	GlycolipidsIBA 01/2021
1	Psychosine (Galactosylsphingosine)IBA 01/2021
1	Sulfoglycosphingolipids (Sulfatides)IBA 01/2021
1	N-Acylsphingosine GalactosyltransferaseIBA 01/2021
1	proto-oncogene proteins pimIBA 01/2017
1	Adenosine Triphosphate (ATP)IBA 11/2015
1	Protein Isoforms (Isoforms)IBA 11/2015
1	Phosphotransferases (Kinase)IBA 11/2015
1	p21-Activated KinasesIBA 06/2015
1	agerafenibIBA 02/2012
1	Pharmaceutical PreparationsIBA 12/2009
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2009
1	AmidesIBA 09/2009
1	Bendamustine Hydrochloride FDA Link 05/2007

Therapy/Procedure

4	Therapeutics 01/2021 - 05/2007
1	Length of Stay 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Aftercare (After-Treatment) 05/2007